Abstract
Worldwide, cervical cancer is one of the leading causes of morbidity and mortality among women. Even though women in developing countries account for approximately 85 % of the cervical cancer cases and deaths, disparities in cervical cancer rates are also documented in developed countries like the United States (U.S.). Recently, formative research conducted in the U.S. and developing countries like South Africa have sought to gain a better understanding of the knowledge, beliefs, and attitudes about cervical cancer prevention, HPV, and the acceptance of the HPV vaccine. This study compares findings from two independent focus group studies. One study was conducted in a segregated township in Johannesburg, South Africa (n = 24) and the other study was conducted in Ohio Appalachia (n = 19). The following seven themes emerged during the discussions from both studies: HPV and cervical cancer; health decision making; parent–child communication; healthy children; HPV vaccine costs; sexual abuse; and HPV vaccine education. Findings from both studies indicate the importance of the role of mothers and grandmothers in the health care decision-making process for children and a lack of awareness of HPV and its association with cervical cancer. While there was interest in the HPV vaccine, participants voiced concern about the vaccine’s cost and side effects. Some participants expressed concern that receipt of the HPV vaccine may initiate adolescent sexual behavior. However, other participants suggested that the HPV vaccine may protect young women who may experience sexual abuse. The importance of developing culturally appropriate educational materials and programs about cervical cancer prevention and the HPV vaccine were expressed by participants in both countries.
Similar content being viewed by others
References
World Health Organization (WHO)/Institut Catala d’Oncologia (ICO). (2010). Information Centre on HPV and Cervical Cancer. Human Papillomavirus and Related Cancers. Summary Report Update 2010. Geneva: WHO/ICO.
World Health Organization (WHO)/Institut Catala d’Oncologia (ICO). (2010). Information Centre on HPV and Cervical Cancer. South Africa: Human Papillomavirus and Related Cancers, Fact Sheet, 2010. Geneva.
World Health Organization (WHO)/Institut Catala d’Oncologia (ICO). (2010). Information Centre on HPV and Cervical Cancer. United States of America: Human Papillomavirus and Related Cancers, Fact Sheet, 2010. Geneva.
Hopenhayn, C., King, J. B., Christian, A., Huang, B., & Christian, W. J. (2008). Variability of cervical cancer rates across 5 Appalachian states, 1998–2003. Cancer, 113, 2974–2980.
Wingo, P. A., Tucker, T. C., Jamison, P. M., Martin, H., McLaughlin, C., Bayakly, R., et al. (2008). Cancer in Appalachia, 2001–2003. Cancer, 112, 181–192.
American Cancer Society. (2009). Cancer Facts and Figures for African Americans, 2009–2010. Atlanta.
American Cancer Society. (2009). Cancer Facts & Figures for Hispanics/Latinos, 2009–2011. Atlanta.
Department of Health and Human Services. Center for Disease Control and Prevention. U.S. Cancer Statistics Working Group. (2010). United States Cancer Statistics: 1999–2007 Incidence and Mortality Web-based Report. Atlanta: Centers for Disease Control and Prevention.
Fisher, J. L., Stephens, J. A., Smith, B. R., Haydu, G. G., Indian, R. W., & Paskett, E. D. (2008). Cancer-related disparities among residents of Appalachia Ohio. Journal of Health Disparities Research and Practice, 2, 61–74.
Wewers, M. E., Katz, M., Fickle, D., & Paskett, E. D. (2006). Risky behaviors among Ohio Appalachian adults. Preventing Chronic Disease, 2006(3), A127.
Paskett, E. D., McLaughlin, J. M., Lehman, A. M., Katz, M. L., Tatum, C. M., & Oliveri, J. M. (2011). Evaluating the efficacy of lay health advisors for increasing risk-appropriate Pap test screening: A randomized controlled trial among Ohio Appalachian women. Cancer Epidemiology Biomarkers and Prevention, 20, 835–843.
Paskett, E. D., McLaughlin, J. M., Reiter, P. L., Lehman, A. M., Rhoda, D. A., Katz, M. L., et al. (2010). Psychosocial predictors of adherence to risk-appropriate cervical cancer screening guidelines: A cross sectional study of women in Ohio Appalachia participating in the Community Awareness Resources and Education (CARE) project. Preventive Medicine, 50, 74–80.
Francis, S. A., Nelson, J., Liverpool, J., Soogun, S., Mofammere, N., & Thorpe, R. J, Jr. (2010). Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa. Vaccine, 28, 8026–8032.
Moodley, J., Kawonga, M., Bradley, J., & Hoffman, M. (2006). Challenges in implementing a cervical screening program in South Africa. Cancer Detection and Prevention, 30, 361–368.
Mosavel, M., Simon, C., van Stade, D., & Buchbinder, M. (2005). Community-based participatory research (CBPR) in South Africa: Engaging multiple constituents to shape the research question. Social Science and Medicine, 61, 2577–2587.
Pillay, A. L. (2002). Rural and urban South African women’s awareness of cancers of the breast and cervix. Ethnicity and Health, 7(2), 103–114.
Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recommendations and Reports, 56(RR-2), 1–24.
Francis, S. A., Battle-Fisher, M., Liverpool, J., Hipple, L., Mosavel, M., Shogun, S., et al. (2011). A qualitative analysis of South African women’s knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health. Vaccine, 29, 8760–8765.
Katz, M. L., Reiter, P. L., Heaner, S., Ruffin, M. T., Post, D. M., & Paskett, E. D. (2009). Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine, 27, 3945–3952.
Marmot, M., & Wilkinson, R. G. (Eds.). (1999). Social Determinants of Health. Oxford: Oxford University Press.
Ice, G. H., Heh, V., & Juma, E. (2011). Caregiving, gender, and nutritional status in Nyanza Province, Kenya: A grandmothers gain, grandfathers lose. American Journal of Biology, 23(4), 498–508.
Goodman, C., & Silverstein, M. (2002). Grandmothers raising grandchildren: Family structure and well-being in culturally diverse families. Gerontologist, 42, 676–689.
Hayslip, B., & Kaminski, P. L. (2005). Grandparents raising their grandchildren: A review of the literature and suggestions for practice. Gerontologist, 45(2), 262–269.
Harries, J., Moodley, J., Barone, M. A., Mall, S., & Sinanovic, E. (2009). Preparing for HPV vaccination in South Africa: Key challenges and opinions. Vaccine, 27, 38–44.
Kahn, J. (2009). HPV vaccination for the prevention of cervical intraepithelial neoplasia. New England Journal of Medicine, 361, 271–278.
Orner, P., Harries, J., Cooper, D., Moodley, J., Hoffman, M., Becker, J., et al. (2006). Challenges to microbicide introduction in South Africa. Social Science and Medicine, 63, 968–978.
Dunkle, K., Jewkes, R., Brown, H., Gray, G., McIntryre, J., & Harlow, S. (2004). Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa. Lancet, 363, 1415–1421.
Brewer, N. T., & Fazekas, K. I. (2007). Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Preventive Medicine, 45, 107–114.
Hughes, J., Cates, J. R., Liddon, N., Smith, J. S., Gottlieb, S. L., & Brewer, N. T. (2009). Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiology Biomarkers and Prevention, 18, 363–372.
Dorell, C. G., Yankey, D., Santibanez, T. A., & Markowitz, L. E. (2011). Human papillomavirus vaccination series initiation and completion, 2008–2009. Pediatrics, 128, 830–839.
Askelson, N. M., Campo, S., Smith, S., Lowe, J. B., Dennis, L. K., & Andsager, J. (2011). The birds, the bees, and the HPVs: what drives mothers’ intentions to use the HPV vaccination as a chance to talk about sex? Journal of Pediatric Health Care, 25, 162–170.
Acknowledgments
The South Africa Women’s Health study was supported by an investigator initiated award from Merck Pharmaceuticals Inc. The contents of this presentation are solely the responsibility of the authors and do not necessarily represent the official views of Merck Inc. The authors would like to thank Dr. Soji Shogun, his clinic staff, and the study participants for providing so much insight. The Ohio Appalachia study was supported by National Cancer Institute Grants:P50CA105632 (PI: Electra Paskett), K07CA107079 (MLK), CA114622 (Appalachia Community Cancer Network), and the P30 CA016058 (Behavioral Measurement Shared Resource at The Ohio State University Comprehensive Cancer Center).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Francis, S.A., Katz, M.L. The HPV Vaccine: A Comparison of Focus Groups Conducted in South Africa and Ohio Appalachia. Matern Child Health J 17, 1222–1229 (2013). https://doi.org/10.1007/s10995-012-1116-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10995-012-1116-6